Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 431 (miR-431) is a conserved, small non-coding RNA transcribed from the antisense strand of the imprinted gene RTL1 and processed as part of several miRNAs in this locus. It regulates gene expression post-transcriptionally and is predominantly expressed in neural and skeletal muscle tissues, where it plays roles in axon regeneration (via targeting Kremen1 and modulating Wnt/beta-catenin signaling), muscle differentiation and regeneration (by silencing Pax7 and SMAD4, key factors in stem cell self-renewal and TGF-β signaling). Age-associated decline of miR-431 impairs muscle regeneration, while supplementation restores regenerative potential. These findings identify miR-431 as a promising therapeutic target for neuromuscular diseases, muscle aging, and potentially for injury recovery; however, there are no approved drugs targeting miR-431 and its safety as a therapeutic remains under basic research investigation.
Gene silencing through binding to 3′ untranslated regions (UTRs) of target mRNAs (Kremen1, Pax7, SMAD4), leading to mRNA degradation or translational inhibition. Downregulation of antagonists or signaling suppressors to promote regeneration (e.g., silencing Wnt pathway inhibitor Kremen1). Modulation of TGF-β signaling pathway via direct targeting of SMAD4, reducing its protein levels and alleviating inhibitory effects on muscle differentiation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 431 (miR-431).